Syngene International Establishes R&D Center for Amgen
The company established a dedicated research center in Bangalore, India for Amgen.
On September 6, 2016, Syngene International, a contract research organization based in Asia, announced that it has established a multi-disciplinary drug discovery and development center for Amgen in Bangalore, India. The center is named Syngene Amgen Research and Development Center (SARC) and is Syngene’s fourth exclusive R&D center. The company currently operates facilities for Bristol-Myers Squibb, Abbott Nutrition, and Baxter.
The center will be staffed by more than 100 Syngene scientists, working in close association with Amgen researchers. The center is customized to meet Amgen’s functional requirements and is configured to minimize solvent and effluent waste.
Syngene has partnered with Amgen in a variety of discovery and development projects. With the establishment of SARC, this association now extends into a multi-discipline collaboration, spanning capabilities in medicinal and process chemistry, biologics, bioprocess, drug metabolism, pharmacokinetics, bioanalytical research, and pharmaceutical development.
Source: Syngene International
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
